Plasma levels of genistein following a single dose of soy extract capsule in Indian women

Indian Journal of Medical Research

Volumn 125, Issue 4, 2007, Pages 534-541

  Joshi, J V ^a   Vaidya, R A ^a   Pandey, S N ^a   Agashe, S ^a   Chandrasekharan, S ^a   Menon, S K ^b   Vaidya, A D B ^a  

^a Bharatiya Vidya Bhavan's Swami Prakashananda Ayurveda Research Centre   (India)

^b Therapeutic Drug Monitoring Laboratory   (India)

Author keywords

Menopause; Phytoestrogens; Plasma genistein levels; Soy isoflovones

Indexed keywords

DAIDZIN; GENISTEIN; GENISTIN; ISOFLAVONE; SOYESTRO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG RESPONSE; ENTEROHEPATIC CIRCULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INDIAN; INFORMED CONSENT; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; SINGLE DRUG DOSE; SOYBEAN; UNSPECIFIED SIDE EFFECT; VEGETARIAN; VOLUNTEER;

ADULT; AREA UNDER CURVE; DIET, VEGETARIAN; FEMALE; GENISTEIN; HUMANS; INDIA; ISOFLAVONES; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 34547129577     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Indian Menopause Society: Menopause and the role of HRT in Indian Women - A Second National Revised Consensus & Policy Development Document, Jha UP, editor. Indian Menopause Society, Delhi; June 2002.
2. Shah RS, Kalgutkar S, Savardekar L, Chitange S, Iddya U, Balaiah D. Menopausal symptoms in urban Indian women. Obstet Gynaecol Today 2004; 9: 772-6.
3. Manson JE, Martin KA. Postmenopausal hormone replacement therapy. N Engl J Med 2001: 345: 34-40.
4. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 2002; 288: 321-33.
5. Beral V, Bull D, Reves G. Million Women Study Collaborators: Endometrial cancer and hormone replacement therapy in the million women study. Lancet 2005; 365: 1543-51.
6. Krebs EE, Ensrud KE, MacDonald R, Wilet TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104: 824-6.
7. Kessel B, Kronenberg F. The role of complementary and alternative medicine in management of menopausal symptoms. Endocrinol Metab Clin North Am 2004; 33: 717-40.
8. Alessandra C, Domenica A, Herbert M, Alessandra B, Domenica C, Herbert M, et al. Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 2005; 12: 186-92.
9. Lambert JD, Hong J, Yang GY, Liao J, Yang CS. Inhibition of carcinogeneses by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 2005; 81: 2845-919.
10. Wakai K, Egami L, Kata K, Kawamura T, Tamakoshi A, Lin Y, et al. Dietary intake and sources of iso-flavones among Japanese. Nutr Cancer 1999; 33: 239-45.
11. Xu X, Wang H, Murphy PA, Hendrich S. Neither background diet nor type of soy food affects short term isoflavone bioavailability in women. J Nutr 2000; 130: 798-801.
12. Wu AH, Yu MC, Tseng C-C, Twaddle NC, Doerge DR. Plasma isoflavone levels versus self reported soy isoflavone levels in Asian-American women in Los-Angeles County. Carcinogenesis 2004; 25: 77-81.
13. Anupongsanugool E, Teekachunhatean S, Rojanasthien N, Pongsatha S, Sangdee C. Pharmacokinetics of isoflavones daidzein and genistein after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women. BMC Clin Pharmacol 2005; 5: 2.
14. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995; 125: 2307-15.
15. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998; 217: 335-9.
16. Faughnan MS, Hawdon AI, An-Singh E, Brown J, Millward DJ, Cassidy A. Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br J Nutr 2004; 91: 567-74.
17. Lundh TJO, Petterson H, Kiessling KH. Liquid chromatographic determination of the estrogens, daidzein, formononetin, coumestrol and equol in bovine blood plasma and urine. J Agri Anal Chem 1988: 71: 938-41.
18. Holder CL, Churchwell MI, Doerge DR. Quantification of soy isoflavones, genistein and daidzein and conjugates, in rat blood using LC/ES-MS. J Agri Food Chem 1999; 47: 3764-70.
19. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimiast L, Wolfe B, Jakate AS, et al. Bioavailability, disposition and dose response effects of soy isoflavones when consumed by healthy women at physiologically typically dietary intakes. J Nutr 2003; 133: 1027-35.
20. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. Br J Nutr 2003; 89(Suppl 1): S45-58.
21. Vedrine N, Mathey J, Morand C, Brandolini M, Davicco MJ, Guy L, et al. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 2006; 60: 1039-45.
22. Back DJ, Orme ML. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet 1990; 18: 472-84.
23. Joshi JV. Bioavailability of oral contraceptive steroids and drug hormone interaction. ICMR Bull 1985; 16: 45-56.
24. Joshi JV, Joshi UM, Sankolli GM, Joseph R. Variability in bioavailability of oral contraceptive steroids in low dose combination pills. Therap Drugs 1991; 8: 13-4.
25. Wiseman H, Sasey K, Bowey EA, Duffy R, Davies M, Rowland IR, et al. Influence of 10 week of soy consumption on plasma concentrations and excretion of isoflavones and on gut microflora metabolism in healthy adults. Am J Clin Nutr 2004; 80: 692-9.
26. Zheng Y, Hu J, Murphy PA, Ajekel DL, Franke WD, Hendrich S. Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women. J Nutr 2003; 133: 3110-6.
27. Walle T, Browning AM, Steed LL, Reed SG, Walle UK. Flavonoid glycosides are hydrolysed and thus activated in the oral cavity in humans. J Nutr 2005; 135: 48-52.
28. Setchell KD, Brzezinski A, Brown NM, Desai PB, Melhem M, Meredith T, et al. Pharmacokinetics of a slow release formulation of soy bean isoflavones in healthy post menopausal women. J Agri Food Chem 2005; 53: 1938-44.
29. Takimoto CH, Glover K, Huang X, Hayes A, Gallot L, Quinn M, et al. Phase 1 pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administeredto individuals with cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 1213-21.